JEIL PHARMACEUTICAL CO.,LTD

Manufacturing facilities for Oral Solid Dosage(OSD) forms

Jeil’s plant for OSD forms was established in 2016 and designed to comply with global GMP standards such as EU-GMP, C-GMP, and PIC/S with a land area of 7,934m^2 and the building area of 13,121m^2. It has an annual production capacity of 12 billion unit dose(tabs./caps.). Remarkably, the High-speed Mixer & Fluid Bed Dryer has a complete closed system, and airtight BIN is used, thereby enabling to prevent any possible contamination from the external environment during the manufacturing processes.

Major equipment

Fluid Bed Granulating Dryer

2 units (5kg, 100kg), Hüttlin(Bosch, Germany) One of the top brands in the world and powder coating up to 10um size is possible. Since both 5kg and 100kg sizes are available, it is applicable to both the R&D and commercial stage. The closed system adopted to minimize the possible contamination from the external environment during the process(from kneading to 2nd mixing)

Double Layer Tablet Press Machine

1 unit , FETTE(Germany) One of the top brands in the world that has excellent tablet pressing, speed, quality. Automatic control of mass, thickness, and hardness. Capacity (39 stations) : 210,000 Single layer tablets/Hr, Double layer tablets/HR. 24 hour unmanned operation function.

Automatic Tablet & Capsule Inspection Machine

1 unit, Enclony (Korea) Both Tablet and Capsule can be inspected and it can sort out 22 defective types of tablets and 13 types of capsules. Capacity : Tablet (280,000T/Hr), Capsules (150,000C/Hr)

Blister Packing Machine

3 units, CAM/Heung-a/JBM Both Blister and Alu-Alu packing are available. Filling, Cartoning, and shrink-wrapping are all automatic.

History

2016	Jeil Health Science (OTC) Spin-off from Jeil Pharm.co., Ltd
2016	Constructed the plant for Oral solid dosage forms
2013	Established Joint venture “Jeil Yao Pharm” with Yao Pharma in China
2012	Constructed new dedicated plants of Cephalosporins(API), AntiCancer(API&FDF), and Utility facility. And enlarged the capacity of the Automated warehouse
2002	Constructed the dedicated plant for Carbapenems (API & FDF)
2001	Approved KGSP(Korean Good Supplying Practice)
1999	Approved BGMP(Bulk Good Manufacturing Practice)
1994	Established Joint Venture “Korea-Yamanouchi Pharm” in Korea with Yamanouchi(Japan)
1991	Established Joint Venture “Jeil-Kirin Pharm” in Korea with Kirin Pharm(Japan)
1990	Established Joint Venture “ Korea-Daiichi Pharm” in Korea with Daiichi(Japan)
1988	IPO in the Korean stock market (Capital: 5 billion Korean won)
1987	Approved KGMP (Korean Good Manufacturing Practice)
1986	Completed the construction of “Baekam plant” (Current plant location: Yongin city, Kyunggi province)
1980	Established “Central R&D Center”
1971	Constructed manufacturing plant (Old plant)
1959	The Company established

Number of Licensed Products

Type of Formulation	Total Number of Licensed Products	Items underproduction
Tablet	78	67
Injection	39	23
Granule	31	30
Capsule	30	18
Cataplasma	20	15
Plaster	7	6
TTS Patch	1	1
Powder	1	1
Solution	3	3
Syrup	1	1
Ophthalmic Solution	1	1
Otic Solution	1	1
Nasal Solution	1	0
Suspension	1	1
Others(Oral Disintegration Film)	1	1
TOTAL	216	169